525 related articles for article (PubMed ID: 3032161)
1. The leukotriene B4 paradox: neutrophils can, but will not, respond to ligand-receptor interactions by forming leukotriene B4 or its omega-metabolites.
Haines KA; Giedd KN; Rich AM; Korchak HM; Weissmann G
Biochem J; 1987 Jan; 241(1):55-62. PubMed ID: 3032161
[TBL] [Abstract][Full Text] [Related]
2. Separation of agonist-stimulated arachidonate mobilization from subsequent leukotriene B4 synthesis in human neutrophils: different effects of oleoylacetylglycerol and phorbol myristate acetate as priming agents.
Rosenthal MD; Franson RC
J Cell Physiol; 1994 Sep; 160(3):522-30. PubMed ID: 8077290
[TBL] [Abstract][Full Text] [Related]
3. Leukotriene B4 paradox: neutrophils can, but will not, respond to ligand-receptor interactions by forming leukotriene B4 or its omega-metabolites.
Haines KA; Giedd KN; Rich AM; Reibman J; Korchak HM; Weissmann G
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():890-9. PubMed ID: 2823576
[No Abstract] [Full Text] [Related]
4. Release of leukotriene B4 from human neutrophils and its relationship to degranulation induced by N-formyl-methionyl-leucyl-phenylalanine, serum-treated zymosan and the ionophore A23187.
Palmer RM; Salmon JA
Immunology; 1983 Sep; 50(1):65-73. PubMed ID: 6309653
[TBL] [Abstract][Full Text] [Related]
5. Modulation of leukotriene release from human polymorphonuclear leucocytes by PMA and arachidonic acid.
Raulf M; König W
Immunology; 1988 May; 64(1):51-9. PubMed ID: 2838420
[TBL] [Abstract][Full Text] [Related]
6. Bacterial lipopolysaccharides prime human neutrophils for enhanced production of leukotriene B4.
Doerfler ME; Danner RL; Shelhamer JH; Parrillo JE
J Clin Invest; 1989 Mar; 83(3):970-7. PubMed ID: 2537852
[TBL] [Abstract][Full Text] [Related]
7. Leukotriene formation by human polymorphonuclear leukocytes from endogenous arachidonate. Physiological triggers and modulation by prostanoids.
Haurand M; Flohé L
Biochem Pharmacol; 1989 Jul; 38(13):2129-37. PubMed ID: 2735951
[TBL] [Abstract][Full Text] [Related]
8. Oxidation of leukotrienes at the omega end: demonstration of a receptor for the 20-hydroxy derivative of leukotriene B4 on human neutrophils and implications for the analysis of leukotriene receptors.
Clancy RM; Dahinden CA; Hugli TE
Proc Natl Acad Sci U S A; 1984 Sep; 81(18):5729-33. PubMed ID: 6091105
[TBL] [Abstract][Full Text] [Related]
9. Phorbol myristate acetate and the calcium ionophore A23187 synergistically induce release of LTB4 by human neutrophils: involvement of protein kinase C activation in regulation of the 5-lipoxygenase pathway.
Liles WC; Meier KE; Henderson WR
J Immunol; 1987 May; 138(10):3396-402. PubMed ID: 3033073
[TBL] [Abstract][Full Text] [Related]
10. Leukotriene B4 metabolism in neutrophils of patients with chronic granulomatous disease: phorbol myristate acetate decreases endogenous leukotriene B4 via NADPH oxidase-dependent mechanism.
Hamasaki T; Sakano T; Kobayashi M; Sakura N; Ueda K; Usui T
Eur J Clin Invest; 1989 Aug; 19(4):404-11. PubMed ID: 2550242
[TBL] [Abstract][Full Text] [Related]
11. Requirement of free arachidonic acid for leukotriene B4 biosynthesis by 12-hydroperoxyeicosatetraenoic acid-stimulated neutrophils.
Kanaji K; Okuma M; Sugiyama T; Sensaki S; Ushikubi F; Uchino H
Biochem Biophys Res Commun; 1986 Jul; 138(2):589-95. PubMed ID: 3017333
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of chemotactic factor-stimulated neutrophil oxidative metabolism by leukotriene B4.
Gay JC; Beckman JK; Brash AR; Oates JA; Lukens JN
Blood; 1984 Oct; 64(4):780-5. PubMed ID: 6089934
[TBL] [Abstract][Full Text] [Related]
13. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils.
Lee TH; Mencia-Huerta JM; Shih C; Corey EJ; Lewis RA; Austen KF
J Clin Invest; 1984 Dec; 74(6):1922-33. PubMed ID: 6096400
[TBL] [Abstract][Full Text] [Related]
14. Intracellular retention of the 5-lipoxygenase pathway product, leukotriene B4, by human neutrophils activated with unopsonized zymosan.
Williams JD; Lee TH; Lewis RA; Austen F
J Immunol; 1985 Apr; 134(4):2624-30. PubMed ID: 2982947
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of leukotriene B4 by activated human polymorphonuclear granulocytes.
Brom J; Schönfeld W; König W
Immunology; 1988 Jul; 64(3):509-18. PubMed ID: 2842254
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the heterogeneous membrane potential response of neutrophils to N-formyl-methionyl-leucyl-phenylalanine (FMLP) by leukotriene B4: evidence for cell recruitment.
Fletcher MP
J Immunol; 1986 Jun; 136(11):4213-9. PubMed ID: 3009618
[TBL] [Abstract][Full Text] [Related]
17. Exogenous leukotriene B4 (LTB4) inhibits human neutrophil generation of LTB4 from endogenous arachidonic acid during opsonized zymosan phagocytosis.
Fiedler J; Wheelan P; Henson PM; Murphy RC
J Pharmacol Exp Ther; 1998 Oct; 287(1):150-6. PubMed ID: 9765334
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of lipoxygenase products on FMLP and LTB4 evoked neutrophil aggregation.
Beckman JK; Gay JC; Brash AR; Lukens JN; Oates JA
Lipids; 1985 Jun; 20(6):357-60. PubMed ID: 2991693
[TBL] [Abstract][Full Text] [Related]
19. Thrombin-activated platelets promote leukotriene B4 synthesis in polymorphonuclear leucocytes stimulated by physiological agonists.
Palmantier R; Borgeat P
Br J Pharmacol; 1991 Aug; 103(4):1909-16. PubMed ID: 1655146
[TBL] [Abstract][Full Text] [Related]
20. Dietary linoleate supplementation modulates formyl-peptide receptor expression and functional responses of rat neutrophils.
Gyllenhammar H; Hafström I; Borgeat P; Ringertz B; Becker W; Svensson J; Palmblad J
J Lab Clin Med; 1990 Apr; 115(4):487-96. PubMed ID: 2157784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]